8
NOV
Reports
Q3, 2023 earnings report expected
SUPN
SUPN
Supernus Pharmaceuticals Inc
32.72
32.72
(0%)
EPS
$0.005
Estimated Sales
$143.39M
Market Cap
$1.3B
Trade
Mentioned
Supernus Pharmaceuticals Inc
SUPN
1.65 (5.29%)
S
32.83
B
32.98
MarketUpdates
United Kingdom
about a year ago
Edited
$SUPN (Supernus Pharmaceuticals Inc) Q3 2023 earnings report is expected to be released
8
NOV
Reports
Q3, 2023 earnings report expected
SUPN
SUPN
Supernus Pharmaceuticals Inc
32.72
32.72
(0%)
EPS
$0.005
Estimated Sales
$143.39M
Market Cap
$1.3B
Trade
Like CommentShare
1 Mentioned
Supernus Pharmaceuticals Inc
SUPN
Supernus Pharmaceuticals Inc